These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 14479512)

  • 21. BLOCKING OF THE IN VIVO EFFECTS OF BRADYKININ AND KALLIDIN WITH CARBOXYPEPTIDASE B.
    ERDOES EG; WOHLER JR; LEVINE MI
    J Pharmacol Exp Ther; 1963 Dec; 142():327-34. PubMed ID: 14098329
    [No Abstract]   [Full Text] [Related]  

  • 22. ENDOGENEOUS PERMEABILITY FACTORS AND THEIR INHIBITORS AFFECTING VASCULAR PERMEABILITY IN CUTANEOUS ARTHUS REACTIONS AND THERMAL INJURY.
    HAYASHI H; YOSHINAGA M; KOONO M; MIYOSHI H; MATSUMURA M
    Br J Exp Pathol; 1964 Aug; 45(4):419-35. PubMed ID: 14203198
    [No Abstract]   [Full Text] [Related]  

  • 23. The chromatographic behaviour of wasp venom kinin, kallidin and bradykinin.
    MATHIAS AP; SCHACHTER M
    Br J Pharmacol Chemother; 1958 Sep; 13(3):326-9. PubMed ID: 13584738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A high performance liquid chromatographic method for the determination of kinin releasing activity of kallikrein.
    Gau W; Haberland GL; Ploschke HJ; Schmidt K
    Adv Exp Med Biol; 1983; 156():483-94. PubMed ID: 6552851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The extraction of human urinary kinin (substance Z) and its relation to the plasma kinins.
    GADDUM JH; HORTON EW
    Br J Pharmacol Chemother; 1959 Mar; 14(1):117-24. PubMed ID: 13651588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression and characterization of human tissue kallikrein variants.
    Chan H; Springman EB; Clark JM
    Protein Expr Purif; 1998 Apr; 12(3):361-70. PubMed ID: 9535704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determinants of the unusual cleavage specificity of lysyl-bradykinin-releasing kallikreins.
    Chagas JR; Portaro FC; Hirata IY; Almeida PC; Juliano MA; Juliano L; Prado ES
    Biochem J; 1995 Feb; 306 ( Pt 1)(Pt 1):63-9. PubMed ID: 7864830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [On the clarification of the structure and synthesis of bradykinin].
    KONZETT H
    Wien Klin Wochenschr; 1961 Feb; 73():119-20. PubMed ID: 13753033
    [No Abstract]   [Full Text] [Related]  

  • 29. Enzymology of porcine tissue kallikrein.
    Fiedler F
    Adv Exp Med Biol; 1983; 156():263-74. PubMed ID: 6552841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. THE RELEASE OF VASCULAR PERMEABILITY FACTORS BY HOMOLOGOUS ANTIGEN AND BY SOLUBLE ANTIGEN-ANTIBODY COMPLEXES IN TISSUE CULTURE AND ITS BIOLOGIC SIGNIFICANCE.
    HAYASHI H; KINUWAKI Y; KOONO M; TAKABA Y
    Lab Invest; 1964 Sep; 13():1124-38. PubMed ID: 14207887
    [No Abstract]   [Full Text] [Related]  

  • 31. [Urinary kallikrein and risk of lead poisoning].
    Iannaccone A; Porcelli G; Boscolo P
    Ann Ist Super Sanita; 1977; 13(1-2):409-16. PubMed ID: 603138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The role of some polypeptides and protein derivatives in inflammation].
    Popescu E
    Stud Cercet Med Interna; 1969; 10(1):29-37. PubMed ID: 4241956
    [No Abstract]   [Full Text] [Related]  

  • 33. [Separation and purification of pancreatic kallikrein].
    HABERMANN E
    Hoppe Seylers Z Physiol Chem; 1962 Jun; 328():15-23. PubMed ID: 13903392
    [No Abstract]   [Full Text] [Related]  

  • 34. [On kinin-producing peptides from pepsin-digested bovine plasma proteins].
    Hochstrasser K; Werle E
    Hoppe Seylers Z Physiol Chem; 1967 Feb; 348(2):177-82. PubMed ID: 5340515
    [No Abstract]   [Full Text] [Related]  

  • 35. [Differentiation between kallikrein and kallikrein elements by means of antiserum and diisopropylfluorophosphate].
    HABERMANN E
    Hoppe Seylers Z Physiol Chem; 1962 Jun; 328():24-30. PubMed ID: 13903391
    [No Abstract]   [Full Text] [Related]  

  • 36. [Biochemistry of bradykinin and kallidin].
    Iwanaga S; Suzuki T
    Seikagaku; 1967 Mar; 39(3):137-51. PubMed ID: 4863331
    [No Abstract]   [Full Text] [Related]  

  • 37. A COMPARISON OF THE EFFECTS OF THE PLASMA KININS, BRADYKININ AND KALLIDIN, ON MYOCARDIAL BLOOD FLOW AND METABOLISM.
    PARRATT JR
    Br J Pharmacol Chemother; 1964 Feb; 22(1):34-46. PubMed ID: 14126055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cold promoted activation of factor VII. 3. Relation to the kallikrein system.
    Gjonnaess H
    Thromb Diath Haemorrh; 1972 Oct; 28(2):182-93. PubMed ID: 4639652
    [No Abstract]   [Full Text] [Related]  

  • 39. Human bradykinin B(2) receptor is activated by kallikrein and other serine proteases.
    Hecquet C; Tan F; Marcic BM; Erdös EG
    Mol Pharmacol; 2000 Oct; 58(4):828-36. PubMed ID: 10999954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crystallization and preliminary crystallographic studies of human kallikrein 7, a serine protease of the multigene kallikrein family.
    Fernández IS; Ständker L; Forssmann WG; Giménez-Gallego G; Romero A
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2007 Aug; 63(Pt 8):669-72. PubMed ID: 17671364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.